EXCLI Journal

metrics 2024

Driving Excellence in Open Access Scientific Publishing

Introduction

EXCLI Journal is an esteemed open access scientific publication dedicated to the fields of Animal Science and Zoology, Drug Discovery, Molecular Medicine, and Pharmacology. Established in 2002 and published by the EXCLI JOURNAL MANAGING OFFICE, this journal has quickly ascended in the academic community, securing a Q1 classification in significant categories like Animal Science and Drug Discovery in the 2023 rankings. With an impressive Scopus Rank of #13 out of 490 in its primary field, the journal maintains high standards for quality research and innovation. The EXCLI Journal is committed to disseminating progressive findings with global relevance, providing a platform for researchers, professionals, and students to engage with cutting-edge studies. With a compelling aim to foster knowledge exchange and collaboration among scientists worldwide, this journal signifies a critical resource for those invested in advancing our understanding of animal science and pharmaceutical research.

Metrics 2024

SCIMAGO Journal Rank0.85
Journal Impact Factor3.80
Journal Impact Factor (5 years)3.90
H-Index55
Journal IF Without Self3.80
Eigen Factor0.00
Normal Eigen Factor0.58
Influence0.72
Immediacy Index1.20
Cited Half Life5.60
Citing Half Life6.30
JCI0.82
Total Documents1331
WOS Total Citations3320
SCIMAGO Total Citations8264
SCIMAGO SELF Citations317
Scopus Journal Rank0.85
Cites / Document (2 Years)3.13
Cites / Document (3 Years)3.24
Cites / Document (4 Years)3.08

Metrics History

Rank 2024

Scopus

Animal Science and Zoology in Agricultural and Biological Sciences
Rank #13/490
Percentile 97.35
Quartile Q1
Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #69/313
Percentile 77.96
Quartile Q1
Drug Discovery in Pharmacology, Toxicology and Pharmaceutics
Rank #37/157
Percentile 76.43
Quartile Q1
Molecular Medicine in Biochemistry, Genetics and Molecular Biology
Rank #52/178
Percentile 70.79
Quartile Q2

IF (Web Of Science)

BIOLOGY
Rank 18/109
Percentile 83.90
Quartile Q1

JCI (Web Of Science)

BIOLOGY
Rank 31/109
Percentile 71.56
Quartile Q2

Quartile History

Similar Journals

International Journal of Clinical and Experimental Medicine

Championing Excellence in Peer-Reviewed Research
Publisher: E-CENTURY PUBLISHING CORPISSN: 1940-5901Frequency: 12 issues/year

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Journal of Research in Medical Sciences

Innovating healthcare through open access.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-1995Frequency: 12 issues/year

Journal of Research in Medical Sciences is a leading open-access journal published by Wolters Kluwer Medknow Publications, dedicated to disseminating innovative research and advancements in the field of medicine. Established in 2005, the journal has earned a respectable Scopus rank of 205 out of 636 in General Medicine, placing it within the 67th percentile among its peers, indicative of its quality and influence in the field. With an Open Access policy adopted in 2015, the journal ensures that critical research findings are accessible to a global audience, thus fostering knowledge sharing and collaboration among researchers, medical professionals, and students. Operating out of Iran, the journal focuses on diverse aspects of medical science, offering a platform for emerging studies that span clinical practices to health-related outcomes. As a recognized publication in the Q3 quartile of medicine (miscellaneous) for 2023, the Journal of Research in Medical Sciences continues to play a pivotal role in promoting scholarly work and advancing medical knowledge, making it an essential resource for anyone invested in the evolution of healthcare and scientific inquiry.

IN VIVO

Driving impactful discoveries in the fight against cancer.
Publisher: INT INST ANTICANCER RESEARCHISSN: 0258-851XFrequency: 6 issues/year

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

BIOMEDICAL PAPERS-OLOMOUC

Fostering collaboration in biochemistry and medicine.
Publisher: PALACKY UNIV, MEDICAL FACISSN: 1213-8118Frequency: 4 issues/year

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

Cyprus Journal of Medical Sciences

Transforming healthcare through rigorous scientific exploration.
Publisher: GALENOS PUBL HOUSEISSN: 2149-7893Frequency: 6 issues/year

Welcome to the Cyprus Journal of Medical Sciences, a distinguished publication dedicated to the advancement of medical knowledge and research. Published by GALENOS PUBL HOUSE, this journal endeavors to uphold the highest standards of scientific inquiry in the medical field. With its ISSN 2149-7893 and E-ISSN 2536-507X, the journal serves as an essential resource for researchers, healthcare professionals, and students seeking to stay abreast of innovative findings and clinical practices. Although currently not listed under Open Access, this journal prioritizes rigorous peer review and the dissemination of impactful research aimed at driving improvements in medical science. The journal welcomes submissions that cover diverse areas within the medical realm, contributing to a more profound understanding of healthcare challenges and solutions. Join us in exploring the frontiers of medical sciences and contributing to a healthier future.

JOURNAL OF ZOO AND WILDLIFE MEDICINE

Exploring innovative solutions in zoo and wildlife medicine.
Publisher: AMER ASSOC ZOO VETERINARIANSISSN: 1042-7260Frequency: 4 issues/year

JOURNAL OF ZOO AND WILDLIFE MEDICINE, published by the American Association of Zoo Veterinarians, serves as a pivotal resource in the field of veterinary science, focusing specifically on the health and well-being of zoo and wildlife species. With an ISSN of 1042-7260 and an E-ISSN of 1937-2825, this journal is recognized for its significant contributions to animal science and has been categorized in the second quartile in both Animal Science and Zoology, as well as Veterinary disciplines, according to the latest rankings. It holds a respectable position within Scopus, being ranked #91 in General Veterinary and #290 in Animal Science and Zoology. While the journal operates on a subscription basis, its impactful research articles have been invaluable for clinicians, researchers, and students alike, providing crucial insights that advance wildlife conservation, veterinary practices, and animal health care from 1993 to the present. With a global reach and a targeted focus on both theoretical and practical applications, JOURNAL OF ZOO AND WILDLIFE MEDICINE is instrumental in fostering collaboration among professionals dedicated to the study and care of wild animal populations.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Pioneering innovative research for a healthier tomorrow.
Publisher: TOHOKU UNIV MEDICAL PRESSISSN: 0040-8727Frequency: 12 issues/year

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

Indonesian Biomedical Journal

Bridging Knowledge Gaps in Biomedical Sciences
Publisher: PRODIA EDUCATION & RESEARCH INSTISSN: 2355-9179Frequency: 3 issues/year

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

Advances in Clinical and Experimental Medicine

Connecting Scholars for a Healthier Tomorrow
Publisher: WROCLAW MEDICAL UNIVISSN: 1899-5276Frequency: 12 issues/year

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Biomedical Research and Therapy

Elevating therapeutic breakthroughs with rigorous insights.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.